Early candidate gene studies using a nested case-control analysis of patients with stage I non-small cell lung cancer (NSCLC), showed that the methylation status of four genes (p16, CDH13, RASSF1A, and APC) correlated with recurrence (Brock et al., 2008). Here, CDKN2A is linked to non-small cell lung carcinoma.